"Labetalol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
| Descriptor ID |
D007741
|
| MeSH Number(s) |
D02.033.100.291.460 D02.065.793.324 D02.092.063.291.460
|
| Concept/Terms |
Dilevalol- Dilevalol
- Labetalol, (R,R)-Isomer
- R,R-Labetalol
- R,R Labetalol
|
Below are MeSH descriptors whose meaning is more general than "Labetalol".
Below are MeSH descriptors whose meaning is more specific than "Labetalol".
This graph shows the total number of publications written about "Labetalol" by people in this website by year, and whether "Labetalol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Labetalol" by people in Profiles.
-
Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study. PLoS One. 2022; 17(5):e0268284.
-
ß-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis. Am J Kidney Dis. 2021 05; 77(5):704-712.
-
Beta-blocker subtypes and risk of low birth weight in newborns. J Clin Hypertens (Greenwich). 2018 11; 20(11):1603-1609.
-
ß-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies. JAMA Intern Med. 2017 06 01; 177(6):885-887.